Analytical Data
-
基因名
CEACAM3
- Application
-
别名
CEACAM3；CD66D；CGM1；Carcinoembryonic antigen-related cell adhesion molecule 3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P40198
-
表达区间
35-155aa
-
氨基酸序列
KLTIESMPLSVAEGKEVLLLVHNLPQHLFGYSWYKGERVDGNSLIVGYVI GTQQATPGAAYSGRETIYTNASLLIQNVTQNDIGFYTLQVIKSDLVNEEA TGQFHVYQENAPGLPVGAVAGVDHHHHHH
-
分子量
14 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CEACAM3 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3) is a member of the CEACAM family of proteins that play significant roles in immune regulation and pathogen recognition. Research into CEACAM3 has gained momentum due to its potential implications in various diseases, particularly cancers and infections. It is primarily expressed on human neutrophils and has been shown to mediate immune responses against bacterial pathogens by facilitating phagocytosis and influencing cytokine production. The study of recombinant CEACAM3 proteins aims to elucidate their structural and functional properties, which can provide insights into their mechanisms of action. Furthermore, as a target for immunotherapy, understanding the interactions and signaling pathways involving CEACAM3 could lead to novel therapeutic strategies for enhancing immune responses against pathogens and cancer cells. Additionally, recombinant CEACAM3 can serve as a valuable tool for studying CEACAM family interactions and their roles in cellular adhesion processes. As such, the exploration of CEACAM3 and its recombinant forms is critical for advancing our knowledge of immune response mechanisms and developing effective interventions in immune-related diseases.
